This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Dr. Stephane Roche, PhD
Founder and CEO at AdaptBio Therapeutics
Speaker

Profile

Stéphane is the founder and CEO of AdaptBio Therapeutics (Est. in 2024). He has 15+ yrs of experience in synthetic and medicinal chemistry in diverse therapeutic areas working on small-molecule natural products and peptide drugs. This rich experience in drug discovery drives his interest in solving complex issues at the interface of science, medicine, and business strategy to create novel medicines that will improve the lives of patients and their families.

Agenda Sessions

  • ADAPT: An Emerging Platform of Antibody CDR-H3 Peptide Scaffolds in the Landscape of Protein-Protein Interaction Inhibitors

    , 11:45am
    View Session

At this event

Prev
Next
Shayak Samaddar, Ph.D
Senior Advisor, Drug Product Formulation
Eli Lilly & Company

See Stephane at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now